INCR
InterCure Ltd.
5.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 54.0% | 75.5% | 67.7% | 68.1% | 75.3% | 66.9% | 66.9% | 99.7% | 69.1% | 69.1% | 99.7% | 99.7% | 84.9% | |
| 46.0% | 24.5% | 32.3% | 31.9% | 24.7% | 33.1% | 33.1% | 0.3% | 30.9% | 30.9% | 0.3% | 0.3% | 15.1% | |
| 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 13.9% | 55.2% | 11.9% | 11.3% | 14.3% | 15.2% | 15.2% | 32.6% | 11.7% | 11.7% | 20.1% | 20.1% | 16.0% | |
| 30.7% | 26.0% | 26.7% | 25.3% | 77.6% | 24.8% | 24.8% | 69.1% | 26.5% | 26.5% | 23.9% | 23.9% | 25.1% | |
| 16.1% | -1.5% | 5.6% | 5.7% | -36.3% | 8.4% | 8.4% | -68.7% | 4.4% | 4.4% | -23.5% | -23.5% | -10.1% | |
| 4.4% | 4.0% | 5.4% | 6.0% | – | 7.2% | 7.2% | 7.9% | 6.2% | 6.2% | 7.2% | 7.2% | 6.7% | |
| 11.9% | -8.3% | 1.7% | 0.4% | -43.2% | 1.2% | 1.2% | -78.5% | -1.8% | -1.8% | -29.8% | -29.8% | -16.3% | |
| 3.6% | -13.2% | 1.6% | -3.2% | 2.6% | 1.2% | 1.2% | -14.2% | -0.4% | -0.4% | -4.9% | -4.9% | -2.7% | |
| 7.2% | 5.0% | 0.2% | 4.8% | -45.6% | 1.1% | 1.1% | -61.2% | -1.3% | -1.3% | -24.3% | -24.3% | -13.2% | |
| 19.0% | -5.8% | 10.0% | 8.8% | -6.5% | 11.5% | 11.5% | -83.2% | 11.0% | 11.0% | -49.6% | -49.6% | -20.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.